Appel, Stanley

Publications

Sort by

Co-Author Network

selected publications

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018 Academic Article GET IT
Times cited: 364
Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations. Annals of neurology. 2017 Academic Article GET IT
Times cited: 23
Post-stroke dyskinesias. Neuropsychiatric disease and treatment. 2016 Review GET IT
Times cited: 10
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy. 2016 Academic Article GET IT
Times cited: 35
Stem cells in amyotrophic lateral sclerosis: Ready for prime time?. Neurology. 2016 Editorial Article GET IT
Times cited: 4
Defining SOD1 ALS natural history to guide therapeutic clinical trial design. Journal of neurology, neurosurgery, and psychiatry. 2016 Academic Article GET IT
Times cited: 52
The immune system continues to knock at the ALS door. Neuromuscular disorders : NMD. 2016 Editorial Article GET IT
Times cited: 3
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome. Experimental neurology. 2015 Academic Article GET IT
Times cited: 132
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2015 Review GET IT
Times cited: 195
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science (New York, N.Y.). 2015 Academic Article GET IT
Times cited: 687
TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta neuropathologica communications. 2014 Academic Article GET IT
Times cited: 62
Seeking a measure of clinically meaningful change in ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2014 Academic Article GET IT
Times cited: 11
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions. Current medical research and opinion. 2014 Academic Article GET IT
Times cited: 26
TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA neurology. 2014 Academic Article GET IT
Times cited: 204
Special issue: A tribute to Jenny S. Henkel, Ph.D. (1955-2013). Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2013 Article GET IT
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2013 Review GET IT
Times cited: 222
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2013 Academic Article GET IT
Times cited: 118
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. The Lancet. Neurology. 2013 Academic Article GET IT
Times cited: 483
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO molecular medicine. 2012 Academic Article GET IT
Times cited: 245
Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62: a functional convergence?. Neurology. 2012 Editorial Article GET IT
Times cited: 6
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta neuropathologica. 2012 Academic Article GET IT
Times cited: 224
Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiology of disease. 2012 Academic Article GET IT
Times cited: 97
Inflammation in Parkinson's disease: cause or consequence?. Movement disorders : official journal of the Movement Disorder Society. 2012 Editorial Article GET IT
Times cited: 27
Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Experimental neurology. 2012 Academic Article GET IT
Times cited: 300
Peripheral nerve inflammation in ALS mice: cause or consequence. Neurology. 2012 Academic Article GET IT
Times cited: 36
Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. PloS one. 2011 Academic Article GET IT
Times cited: 48
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 2011 Academic Article GET IT
Times cited: 63
The microglial-motoneuron dialogue in ALS. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology. 2011 Review GET IT
Times cited: 152
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain : a journal of neurology. 2011 Academic Article GET IT
Times cited: 272
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain, behavior, and immunity. 2010 Academic Article GET IT
Times cited: 142
Trauma, TDP-43, and amyotrophic lateral sclerosis. Muscle & nerve. 2010 Editorial Article GET IT
Times cited: 7
Does apolipoprotein E genotype modify the clinical expression of ALS?. European journal of neurology. 2010 Academic Article GET IT
Times cited: 15
Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010 Review GET IT
Times cited: 63
Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 2010 Academic Article GET IT
Times cited: 212
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. European journal of neurology. 2010 Academic Article GET IT
Times cited: 73
Association between dysarthria and cognitive impairment in ALS: A prospective study. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010 Academic Article GET IT
Times cited: 18
Microglia in ALS: the good, the bad, and the resting. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2009 Review GET IT
Times cited: 267
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?. Trends in immunology. 2009 Review GET IT
Times cited: 207
Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. European journal of neurology. 2009 Academic Article GET IT
Times cited: 100
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology. 2009 Letter GET IT
Times cited: 17
Abnormal serum concentrations of proteins in Parkinson's disease. Biochemical and biophysical research communications. 2009 Academic Article GET IT
Times cited: 16
SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology. 2009 Academic Article GET IT
Times cited: 36
Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 2009 Academic Article GET IT
Times cited: 107
Alzheimer research forum live discussion: mice on trial? Issues in the design of drug studies. Journal of Alzheimer's disease : JAD. 2009 Academic Article GET IT
CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. The Journal of clinical investigation. 2009 Academic Article GET IT
Times cited: 81
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology. 2008 Academic Article GET IT
Times cited: 210
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 2008 Academic Article GET IT
Times cited: 114
CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proceedings of the National Academy of Sciences of the United States of America. 2008 Academic Article GET IT
Times cited: 360
Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosis. Current neurology and neuroscience reports. 2008 Review GET IT
Times cited: 2
Immunotherapy for neurological diseases. Clinical immunology (Orlando, Fla.). 2008 Review GET IT
Times cited: 43
ALSFRS and appel ALS scores: discordance with disease progression. Muscle & nerve. 2008 Academic Article GET IT
Times cited: 30
Cognitive impairment in familial ALS. Neurology. 2007 Academic Article GET IT
Times cited: 47
Phase II/III randomized trial of TCH346 in patients with ALS. Neurology. 2007 Academic Article GET IT
Times cited: 105
Whole-genome analysis of sporadic amyotrophic lateral sclerosis. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 212
Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. Journal of neurochemistry. 2007 Academic Article GET IT
Times cited: 125
Predictability of disease progression in amyotrophic lateral sclerosis. Muscle & nerve. 2006 Academic Article GET IT
Times cited: 46
The value of database controls in pilot or futility studies in ALS. Neurology. 2006 Academic Article GET IT
Times cited: 16
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2006 Academic Article GET IT
Times cited: 574
Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. Journal of neurochemistry. 2006 Academic Article GET IT
Times cited: 122
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Archives of neurology. 2006 Academic Article GET IT
Times cited: 68
Amyotrophic lateral sclerosis: early predictors of prolonged survival. Journal of neurology. 2006 Academic Article GET IT
Times cited: 97
Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. Journal of neurology, neurosurgery, and psychiatry. 2006 Academic Article GET IT
Times cited: 187
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochemical and biophysical research communications. 2006 Academic Article GET IT
Times cited: 106
Is ALS a systemic disorder? Evidence from muscle mitochondria. Experimental neurology. 2006 Academic Article GET IT
Times cited: 19
2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases. Expert review of proteomics. 2006 Review GET IT
Times cited: 50
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Molecular and cellular neurosciences. 2005 Academic Article GET IT
Times cited: 141
Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery. 2005 Academic Article GET IT
Times cited: 16
Promoting excellence in end-of-life care in ALS. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2005 Review GET IT
Times cited: 70
"Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers" by Lo Coco G, Lo Coco D, Cicero V, Oliveri A, Lo Verso G, Piccolo F, La Bella V. Journal of the neurological sciences. 2005 Editorial Article GET IT
Times cited: 2
Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005 Academic Article GET IT
Times cited: 668
Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. Journal of neuroscience research. 2005 Academic Article GET IT
Times cited: 76
Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo. Acta neuropathologica. 2005 Academic Article GET IT
Times cited: 13
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004 Academic Article GET IT
Times cited: 221
Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. Toxicology. 2004 Academic Article GET IT
Times cited: 70
Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. Journal of neuropathology and experimental neurology. 2004 Academic Article GET IT
Times cited: 135
Design using historical controls. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2004 Academic Article GET IT
Times cited: 2
Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology. 2004 Academic Article GET IT
Times cited: 258
HFE mutations are not strongly associated with sporadic ALS. Neurology. 2004 Academic Article GET IT
Times cited: 39
Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregivers. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2004 Academic Article GET IT
Times cited: 38
Mutant genes responsible for Parkinson's disease. Current opinion in pharmacology. 2004 Review GET IT
Times cited: 28
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Annals of neurology. 2004 Academic Article GET IT
Times cited: 435
Widespread increased expression of the DNA repair enzyme PARP in brain in ALS. Neurology. 2004 Academic Article GET IT
Times cited: 51
Euthanasia and physician-assisted suicide in ALS: a commentary. The American journal of hospice & palliative care. 2004 Editorial Article GET IT
Times cited: 3
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Current opinion in rheumatology. 2003 Review GET IT
Times cited: 90
Role of nitric oxide in rotenone-induced nigro-striatal injury. Journal of neurochemistry. 2003 Academic Article GET IT
Times cited: 120
Serum anti-Fas antibody levels in amyotrophic lateral sclerosis. Journal of neuroimmunology. 2003 Academic Article GET IT
Times cited: 21
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003 Academic Article GET IT
Times cited: 195
Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. Journal of palliative medicine. 2003 Academic Article GET IT
Times cited: 51
A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. Journal of the neurological sciences. 2003 Academic Article GET IT
Times cited: 136
PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. Journal of neuropathology and experimental neurology. 2003 Academic Article GET IT
Times cited: 51
Mutations in NR4A2 associated with familial Parkinson disease. Nature genetics. 2002 Academic Article GET IT
Times cited: 408
Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Experimental neurology. 2002 Academic Article GET IT
Times cited: 78
Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. Journal of neuroscience research. 2002 Academic Article GET IT
Times cited: 79
Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium. Advances in neurology. 2002 Review GET IT
Times cited: 12
Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2001 Academic Article GET IT
Times cited: 258
Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. Journal of neurochemistry. 2001 Academic Article GET IT
Times cited: 123
Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001 Academic Article GET IT
Times cited: 356
Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain research. 2001 Academic Article GET IT
Times cited: 298
Activated microglia: the silent executioner in neurodegenerative disease?. Current neurology and neuroscience reports. 2001 Review GET IT
Times cited: 16
Adult-onset combined methylmalonic aciduria and homocystinuria (cblC). 2001 GET IT
Times cited: 51
Calcium: the Darth Vader of ALS. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2001 Review GET IT
Times cited: 59
Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. Archives of physical medicine and rehabilitation. 2001 Academic Article GET IT
Times cited: 41
Altered calcium homeostasis in spinal motoneurons but not in oculomotor neurons of SOD-1 knockout mice. Acta neuropathologica. 2000 Academic Article GET IT
Times cited: 16
Stereotaxic injection of IgG from patients with Alzheimer disease initiates injury of cholinergic neurons of the basal forebrain. Archives of neurology. 2000 Academic Article GET IT
Times cited: 17
Ultrastructural evidence of calcium involvement in experimental autoimmune gray matter disease. Journal of neuroscience research. 2000 Academic Article GET IT
Times cited: 5
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice. Neuroscience letters. 2000 Academic Article GET IT
Times cited: 98
Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology. 2000 Academic Article GET IT
Times cited: 29
Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. Journal of neural transmission (Vienna, Austria : 1996). 2000 Academic Article GET IT
Times cited: 94
Hippocampal cholinergic neurostimulating peptides (HCNP). Progress in neurobiology. 2000 Review GET IT
Times cited: 107
Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. Journal of neurochemistry. 1999 Academic Article GET IT
Times cited: 161
Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Experimental neurology. 1999 Academic Article GET IT
Times cited: 125
T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurobiology of disease. 1999 Academic Article GET IT
Times cited: 26
Brain choline acetyltransferase and mental function in Alzheimer disease. Archives of neurology. 1999 Academic Article GET IT
Times cited: 66
Calcium-containing endosomes at oculomotor terminals in animal models of ALS. Neuroreport. 1999 Academic Article GET IT
Times cited: 11
Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. Journal of neuroscience research. 1999 Academic Article GET IT
Times cited: 148
Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Archives of neurology. 1999 Academic Article GET IT
Times cited: 46
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity. Life sciences. 1999 Academic Article GET IT
Times cited: 103
Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Annals of neurology. 1998 Academic Article GET IT
Times cited: 322
Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Annals of neurology. 1998 Academic Article GET IT
Times cited: 201
Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation. Journal of neuroscience research. 1998 Academic Article GET IT
Times cited: 60
Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Archives of neurology. 1998 Academic Article GET IT
Times cited: 99
Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. Journal of neuropathology and experimental neurology. 1998 Academic Article GET IT
Times cited: 116
Role of potassium channels in amyloid-induced cell death. Journal of neurochemistry. 1998 Academic Article GET IT
Times cited: 145
1Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells. Journal of neuroscience research. 1998 Academic Article GET IT
Times cited: 62
Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis. Archives of neurology. 1998 Academic Article GET IT
Times cited: 65
The differential in vitro stimulation of 3',5'-cyclic nucleotide phosphodiesterase by calcium binding proteins. Biochemistry and molecular biology international. 1997 Academic Article GET IT
Times cited: 1
Modulation of septal cell activity by extracellular zinc. Neuroreport. 1997 Academic Article GET IT
Times cited: 6
Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein. Journal of neurochemistry. 1997 Academic Article GET IT
Times cited: 49
Immunization of guinea pigs with human choline acetyltransferase induces selective lower motoneuron destruction. Journal of neuroimmunology. 1997 Academic Article GET IT
Times cited: 11
Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Experimental neurology. 1997 Academic Article GET IT
Times cited: 32
Experimental immune-mediated damage of septal cholinergic neurons. Journal of neuroimmunology. 1997 Academic Article GET IT
Times cited: 24
Increased CSF glutamate following injection of ALS immunoglobulins. Neurology. 1997 Academic Article GET IT
Times cited: 20
(-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition. Neuroscience letters. 1997 Academic Article GET IT
Times cited: 41
Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. Journal of neuropathology and experimental neurology. 1997 Academic Article GET IT
Times cited: 45
Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry. 1996 Academic Article GET IT
Times cited: 231
Autoimmunity and ALS. Neurology. 1996 Review GET IT
Times cited: 46
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 1996 Academic Article GET IT
Times cited: 347
Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. Lancet (London, England). 1996 Letter GET IT
Times cited: 34
Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1996 Academic Article GET IT
Times cited: 83
Calbindin D28K forms a Ca(2+)-dissociable complex with mellitin in vitro. Biochemistry and molecular biology international. 1996 Academic Article GET IT
Times cited: 6
Apoptosis induced by beta-N-oxalylamino-L-alanine on a motoneuron hybrid cell line. Neuroscience. 1996 Academic Article GET IT
Times cited: 20
Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Annals of neurology. 1996 Academic Article GET IT
Times cited: 261
Immune-mediated cell death in neurodegenerative disease. Advances in neurology. 1996 Review GET IT
Times cited: 18
beta-Amyloid1-40 increases expression of beta-amyloid precursor protein in neuronal hybrid cells. Journal of neurochemistry. 1995 Academic Article GET IT
Times cited: 19
Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. Journal of the neurological sciences. 1995 Academic Article GET IT
Times cited: 114
Alpha-1 subunits of voltage gated Ca2+ channels in the mesencephalon x neuroblastoma hybrid cell line MES23.5. Neuroscience. 1995 Academic Article GET IT
Times cited: 5
Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain research. 1995 Academic Article GET IT
Times cited: 141
Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse (New York, N.Y.). 1995 Academic Article GET IT
Times cited: 88
Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease. Muscle & nerve. 1995 Academic Article GET IT
Times cited: 8
Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain : a journal of neurology. 1995 Academic Article GET IT
Times cited: 629
Experimental autoimmune nigral damage in guinea pigs. Journal of neuroimmunology. 1995 Academic Article GET IT
Times cited: 32
Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line. Annals of neurology. 1995 Academic Article GET IT
Times cited: 73
Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis. Advances in neurology. 1995 Review GET IT
Times cited: 30
Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clinical neuroscience (New York, N.Y.). 1995 Review GET IT
Times cited: 40
Molecular approaches to amyotrophic lateral sclerosis. Annual review of medicine. 1995 Review GET IT
Times cited: 34
Neurotoxicity of A beta amyloid protein in vitro is not altered by calcium channel blockade. Neurobiology of aging. 1995 Academic Article GET IT
Times cited: 40
Neurodegenerative disease: autoimmunity involving calcium channels. Annals of the New York Academy of Sciences. 1994 Review GET IT
Times cited: 12
Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. Journal of neurochemistry. 1994 Academic Article GET IT
Times cited: 62
The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Annals of neurology. 1994 Academic Article GET IT
Times cited: 317
Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Annals of neurology. 1994 Letter GET IT
Times cited: 11
Decremental motor responses to repetitive nerve stimulation in ALS. Muscle & nerve. 1994 Academic Article GET IT
Times cited: 74
Evidence for autoimmunity in amyotrophic lateral sclerosis. Journal of the neurological sciences. 1994 Review GET IT
Times cited: 50
Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proceedings of the National Academy of Sciences of the United States of America. 1994 Academic Article GET IT
Times cited: 121
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochemical and biophysical research communications. 1994 Academic Article GET IT
Times cited: 65
Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Annals of neurology. 1994 Academic Article GET IT
Times cited: 89
Molecular analysis and functional expression of the human type E neuronal Ca2+ channel alpha 1 subunit. Receptors & channels. 1994 Academic Article GET IT
Times cited: 149
IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proceedings of the National Academy of Sciences of the United States of America. 1993 Academic Article GET IT
Times cited: 86
Modulation of acetylcholine release in rat hippocampus by amino alcohols and Bay K 8644. Brain research. 1993 Academic Article GET IT
Times cited: 6
Can neurotrophic factors prevent or reverse motoneuron injury in amyotrophic lateral sclerosis?. Experimental neurology. 1993 Review GET IT
Times cited: 14
Evidence for autoimmunity in amyotrophic lateral sclerosis. Journal of the neurological sciences. 1993 Review GET IT
Times cited: 71
Antibodies to L-type calcium channels in amyotrophic lateral sclerosis. The New England journal of medicine. 1993 Letter GET IT
Times cited: 6
Fab fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle. The American journal of physiology. 1993 Academic Article GET IT
Times cited: 17
The action of amyotrophic lateral sclerosis immunoglobulins on mammalian single skeletal muscle Ca2+ channels. The Journal of physiology. 1993 Academic Article GET IT
Times cited: 28
Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. Trends in neurosciences. 1993 Review GET IT
Times cited: 66
Experimental immune-mediated motor neuron diseases: models for human ALS. Brain research bulletin. 1993 Review GET IT
Times cited: 23
Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Archives of neurology. 1993 Academic Article GET IT
Times cited: 243
Vimentin-crossreactive antibodies induce cell death in primary cultures of embryonic spinal cord. Journal of neuroimmunology. 1993 Academic Article GET IT
Times cited: 2
The Lambert-Eaton syndrome. Hospital practice (Office ed.). 1992 Review GET IT
Times cited: 8
Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. The New England journal of medicine. 1992 Academic Article GET IT
Times cited: 173
Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology. 1992 Academic Article GET IT
Times cited: 38
Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs. Annals of neurology. 1992 Academic Article GET IT
Times cited: 39
A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1992 Academic Article GET IT
Times cited: 157
Ca2+ current and charge movement in adult single human skeletal muscle fibres. The Journal of physiology. 1992 Academic Article GET IT
Times cited: 24
Phosphoethanolamine enhances high-affinity choline uptake and acetylcholine synthesis in dissociated cell cultures of the rat septal nucleus. Journal of neurochemistry. 1992 Academic Article GET IT
Times cited: 9
Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. Brain research. Developmental brain research. 1992 Academic Article GET IT
Times cited: 36
Amino alcohol modulation of hippocampal acetylcholine release. Neuroreport. 1992 Academic Article GET IT
Times cited: 5
Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. The American journal of pathology. 1992 Academic Article GET IT
Times cited: 130
Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins. The Journal of physiology. 1991 Academic Article GET IT
Times cited: 54
Cyclophosphamide alters the clinical and pathological expression of experimental autoimmune gray matter disease. Journal of neuroimmunology. 1991 Academic Article GET IT
Times cited: 13
IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle. The American journal of physiology. 1991 Academic Article GET IT
Times cited: 32
Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Archives of neurology. 1991 Academic Article GET IT
Times cited: 103
Trophic effect of angiotensin II, vasopressin and other peptides on the cultured ventral spinal cord of rat embryo. Journal of the neurological sciences. 1991 Academic Article GET IT
Times cited: 31
A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology. 1991 Academic Article GET IT
Times cited: 167
Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proceedings of the National Academy of Sciences of the United States of America. 1991 Academic Article GET IT
Times cited: 109
Amyotrophic lateral sclerosis mortality rates in Harris County, Texas. Advances in neurology. 1991 Academic Article GET IT
Times cited: 7
Autoimmunity and ALS: a comparison of animal models of immune-mediated motor neuron destruction and human ALS. Advances in neurology. 1991 Review GET IT
Times cited: 32
Immune-mediated models of motor neuron destruction in the guinea pig. Advances in neurology. 1991 Academic Article GET IT
Times cited: 5
IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Archives of neurology. 1990 Academic Article GET IT
Times cited: 189
Increased MEPP frequency as an early sign of experimental immune-mediated motoneuron disease. Annals of neurology. 1990 Academic Article GET IT
Times cited: 18
Motor neuron reactivity of sera from animals with autoimmune models of motor neuron destruction. Journal of the neurological sciences. 1990 Academic Article GET IT
Times cited: 14
Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease. Journal of neuroimmunology. 1990 Academic Article GET IT
Times cited: 68
An animal model of motor neuron disease in guinea pigs. Progress in brain research. 1990 Academic Article GET IT
Future prospects of research on central cholinergic mechanisms. Progress in brain research. 1990 Review GET IT
Times cited: 4
Experimental autoimmune motoneuron disease. Annals of neurology. 1989 Academic Article GET IT
Times cited: 77
Mental status assessment of insight and judgment. Clinics in geriatric medicine. 1989 Review GET IT
Times cited: 2
Purification and characterization of a central cholinergic enhancing factor from rat brain: its identity as phosphoethanolamine. Journal of neurochemistry. 1989 Academic Article GET IT
Times cited: 10
Trophic effects of skeletal muscle extracts on spinal cord cultures. The International journal of neuroscience. 1989 Academic Article GET IT
Times cited: 4
Identification of basic fibroblast growth factor as a cholinergic growth factor from human muscle. Journal of neuroscience research. 1989 Academic Article GET IT
Times cited: 36
Muscle-derived trophic factors influencing cholinergic neurons in vitro and in vivo. Progress in brain research. 1989 Review GET IT
Times cited: 8
Will neurotrophic agents be harmful in Alzheimer's disease?. Neurobiology of aging. 1989 Academic Article GET IT
Times cited: 2
Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proceedings of the National Academy of Sciences of the United States of America. 1988 Academic Article GET IT
Times cited: 54
Reduction of naturally occurring motoneuron death in vivo by a target-derived neurotrophic factor. Science (New York, N.Y.). 1988 Academic Article GET IT
Times cited: 197
Purification of a skeletal muscle polypeptide which stimulates choline acetyltransferase activity in cultured spinal cord neurons. The Journal of biological chemistry. 1988 Academic Article GET IT
Times cited: 59
A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis. Archives of neurology. 1988 Academic Article GET IT
Times cited: 79
Developmental discord among markers for cholinergic differentiation: in vitro time courses for early expression and responses to skeletal muscle extract. Developmental biology. 1988 Academic Article GET IT
Times cited: 13
Trophic factors in neurologic disease. Annual review of medicine. 1988 Review GET IT
Times cited: 28
Distinct influences of nerve growth factor and a central cholinergic trophic factor on medial septal explants. Brain research. 1987 Academic Article GET IT
Times cited: 25
A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Annals of neurology. 1987 Academic Article GET IT
Times cited: 197
Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain research. 1986 Academic Article GET IT
Times cited: 124
Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Archives of neurology. 1986 Academic Article GET IT
Times cited: 107
Selective effects of skeletal muscle extract fractions on motoneuron development in vitro. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1986 Academic Article GET IT
Times cited: 77
Chronic renal failure presenting as proximal muscle weakness in a child. 1986 GET IT
Times cited: 4
Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins. Neurology. 1985 Academic Article GET IT
Times cited: 15
Low-molecular-weight peptide stimulates cholinergic development in ventral spinal cord cultures. Developmental biology. 1985 Academic Article GET IT
Times cited: 10
Trophic effects of skeletal muscle extracts on ventral spinal cord neurons in vitro: separation of a protein with morphologic activity from proteins with cholinergic activity. The Journal of cell biology. 1985 Academic Article GET IT
Times cited: 53
Choice reaction time modifiability in dementia and depression. The International journal of neuroscience. 1985 Academic Article GET IT
Times cited: 12
Differential morphologic effects of two fractions from fetal calf muscle on cultured chick ciliary ganglion cells. Brain research. 1985 Academic Article GET IT
Times cited: 4
Endogenous inhibitor of ligand binding to the muscarinic acetylcholine receptor. Journal of neurochemistry. 1985 Academic Article GET IT
Times cited: 23
Immunopathologic events at the endplate in myasthenia gravis. Springer seminars in immunopathology. 1985 Review GET IT
Times cited: 20
Magnetic resonance imaging in multiple sclerosis: results in 32 cases. AJNR. American journal of neuroradiology. 1985 Academic Article GET IT
Times cited: 62
Neurotrophic effects of hippocampal extracts on medial septal nucleus in vitro. Proceedings of the National Academy of Sciences of the United States of America. 1984 Academic Article GET IT
Times cited: 67
Organization of acetylcholine receptor clusters in cultured rat myotubes is calcium dependent. The Journal of cell biology. 1984 Academic Article GET IT
Times cited: 16
Extracts of skeletal muscle increase neurite outgrowth and cholinergic activity of fetal rat spinal motor neurons. Science (New York, N.Y.). 1983 Academic Article GET IT
Times cited: 103
Myasthenic globulin enhances the loss of acetylcholine receptor clusters. Science (New York, N.Y.). 1983 Academic Article GET IT
Times cited: 13
Acetylcholine receptor turnover in myasthenia gravis. The American journal of physiology. 1982 Academic Article GET IT
Times cited: 1
Inhibitors of membrane depolarization regulate acetylcholine receptor synthesis by a calcium-dependent, cyclic nucleotide-independent mechanism. Biochimica et biophysica acta. 1982 Academic Article GET IT
Times cited: 17
Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes. Annals of neurology. 1982 Academic Article GET IT
Times cited: 7
Research in neuromuscular disease. Cardiovascular Research Center bulletin. 1982 Academic Article GET IT
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Annals of neurology. 1981 Academic Article GET IT
Times cited: 544
Myotonic dystrophy: calcium-dependent phosphatidic acid synthesis in erythrocytes. Annals of neurology. 1981 Academic Article GET IT
Times cited: 4
The effect of calcium on acetylcholine receptor synthesis. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1981 Academic Article GET IT
Times cited: 23
Electrophysiology of human muscle in culture. Experimental neurology. 1981 Academic Article GET IT
Times cited: 8
Cultured muscle from myotonic muscular dystrophy patients: altered membrane electrical properties. Proceedings of the National Academy of Sciences of the United States of America. 1981 Academic Article GET IT
Times cited: 32
Multiple sclerosis--new ideas and a new test. 1981 GET IT
The effects of carbamylcholine, calcium, and cyclic nucleotides on acetylcholine receptor synthesis in cultured myotubes. Annals of the New York Academy of Sciences. 1981 Academic Article GET IT
Times cited: 3
Methylation of erythrocyte membrane phospholipids in patients with myotonic and Duchenne muscular dystrophy. Experimental neurology. 1980 Academic Article GET IT
Times cited: 8
Regulation of acetylcholine receptor by cyclic AMP. The Journal of biological chemistry. 1980 Academic Article GET IT
Times cited: 32
Red blood cell alterations in muscular dystrophy: the role of lipids. Muscle & nerve. 1980 Review GET IT
Times cited: 39
The role of acetylcholine receptor antibodies in myasthenia gravis. Federation proceedings. 1979 Academic Article GET IT
Times cited: 21
Current concepts of pathogenesis and treatment of myasthenia gravis. The Medical clinics of North America. 1979 Review GET IT
Times cited: 9
Neonatal myasthenia gravis in the infant of a myasthenic mother in remission. Annals of neurology. 1979 Academic Article GET IT
Times cited: 34
Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin. Annals of neurology. 1978 Academic Article GET IT
Times cited: 7
Denervation alterations in surface membrane glycoprotein glycosyltransferases of mammalian skeletal muscle. Experimental neurology. 1978 Academic Article GET IT
Times cited: 17
The muscular dystrophies. Clinical update on two major types. Postgraduate medicine. 1978 Academic Article GET IT
Times cited: 2
Characterization of the beta-adrenergic receptor and adenylate cyclase in skeletal muscle plasma membranes. Archives of biochemistry and biophysics. 1978 Academic Article GET IT
Times cited: 20
Properties and distribution of mammalian skeletal muscle guanylate cyclase. Alterations in denervated and dystrophic muscle. The Journal of biological chemistry. 1978 Academic Article GET IT
Times cited: 11
beta-adrenergic receptor-adenylate cyclase of denervated sarcolemmal membrane. Experimental neurology. 1978 Academic Article GET IT
Times cited: 13
Myotonic muscular dystrophy: altered calcium transport in erythrocytes. Science (New York, N.Y.). 1978 Academic Article GET IT
Times cited: 58
The role of acetylcholine receptor antibodies in the pathogenesis of myasthenia gravis. 1978 GET IT
Is there acetylcholine receptor in human thymus?. Journal of the neurological sciences. 1977 Academic Article GET IT
Times cited: 11
Development of denervation alterations in surface membranes of mammalian skeletal muscle. Experimental neurology. 1977 Academic Article GET IT
Times cited: 19
Myelin basic protein phosphatase activity in rat brain. Journal of neurochemistry. 1977 Academic Article GET IT
Times cited: 19
Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes. Nature. 1977 Academic Article GET IT
Times cited: 29
Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proceedings of the National Academy of Sciences of the United States of America. 1977 Academic Article GET IT
Times cited: 110
Isolation and characterization of the surface membranes of fast and slow mammalian skeletal muscle. Biochimica et biophysica acta. 1977 Academic Article GET IT
Times cited: 25
Biochemical approaches to dementia. Contemporary neurology series. 1977 Review GET IT
Times cited: 1
Cholinergic sites in skeletal muscle: interaction with concanavalin A. Journal of neurochemistry. 1976 Academic Article GET IT
Times cited: 12
Electron spin resonance studies of membrane proteins in erythrocytes in myotonic muscular dystrophy. Archives of biochemistry and biophysics. 1976 Academic Article GET IT
Times cited: 70
Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy. Journal of the neurological sciences. 1976 Academic Article GET IT
Times cited: 32
Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy. Journal of the neurological sciences. 1976 Academic Article GET IT
Times cited: 41
Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne muscular dystrophy and congenital myotonia. Nature. 1976 Academic Article GET IT
Times cited: 79
Recent advances in myasthenia gravis. Life sciences. 1976 Review GET IT
Times cited: 5
Scanning electron microscopy studies in muscular dystrophy. Archives of neurology. 1976 Academic Article GET IT
Times cited: 60
Carrier detection in Duchenne muscular dystrophy. The New England journal of medicine. 1976 Academic Article GET IT
Times cited: 77
Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Annals of the New York Academy of Sciences. 1976 Academic Article GET IT
Times cited: 24
Serum acetylcholine-receptor antibodies in myasthenia gravis. Annals of the New York Academy of Sciences. 1976 Review GET IT
Times cited: 27
Acetylcholine receptor antibodies in myasthenia gravis. The New England journal of medicine. 1975 Academic Article GET IT
Times cited: 177
Neuronal recognition and synaptogenesis. Experimental neurology. 1975 Academic Article GET IT
Times cited: 14
Phenytoin and membrane fluidity in myotonic dystrophy. Archives of neurology. 1975 Academic Article GET IT
Times cited: 17
Letter: Erythrocytes in human muscular dystrophy. Science (New York, N.Y.). 1975 Academic Article GET IT
Times cited: 7
Macromolecular characterization of muscle membranes. Endogenous membrane kinase and phosphorylated protein substrate from normal and denervated muscle. The Journal of biological chemistry. 1975 Academic Article GET IT
Times cited: 23
Membrane protein kinase alteration in Duchenne muscular dystrophy. Nature. 1975 Academic Article GET IT
Times cited: 106
Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy. The Journal of membrane biology. 1975 Academic Article GET IT
Times cited: 78
Specificity of biochemical and biophysical tests in Duchenne and myotonic muscular dystrophy, carrier states, and congenital myotonia. Transactions of the American Neurological Association. 1975 Academic Article GET IT
Times cited: 1
Acetylcholine receptor in normal and denervated slow and fast muscle. Biochemistry. 1974 Academic Article GET IT
Times cited: 40
Letter: Muscular dystrophies. Lancet (London, England). 1974 Academic Article GET IT
Times cited: 18
A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy. Biochemistry. 1974 Academic Article GET IT
Times cited: 66
Phosphatidyl inositol turnover in muscle membranes following denervation. Journal of neurochemistry. 1974 Academic Article GET IT
Times cited: 12
Macromolecular characterization of muscle membranes. Acetylcholine receptor of normal and denervated muscle. The Journal of biological chemistry. 1974 Academic Article GET IT
Times cited: 18
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science (New York, N.Y.). 1974 Academic Article GET IT
Times cited: 297
Phosphorylation of myelin basic protein. The Journal of biological chemistry. 1974 Academic Article GET IT
Times cited: 63
Muscle membrane protein kinase in myotonic muscular dystrophy. Nature. 1974 Academic Article GET IT
Times cited: 59
Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 1974 Academic Article GET IT
Times cited: 67
Biochemical studies of transneuronal degeneration: the effects of enucleation on the biochemical maturation of the chick optic tectum. Brain research. 1974 Academic Article GET IT
Times cited: 14
Developmental changes in the incorporation in vitro of (3H) fucose in normal and deafferentiated optic tecta. Archives internationales de physiologie et de biochimie. 1973 Academic Article GET IT
Phosphorylation of muscle membranes: identification of a membrane-bound protein kinase. Science (New York, N.Y.). 1973 Academic Article GET IT
Times cited: 25
Macromolecular characterization of muscle membranes. I. Proteins and sialic acid of normal and denervated muscle. The Journal of biological chemistry. 1973 Academic Article GET IT
Times cited: 64
Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 1973 Academic Article GET IT
Times cited: 108
The contribution of axoplasmic flow in optic nerve and protein synthesis within the optic tectum to synaptic membrane proteins of the chick optic tectum. Journal of neurochemistry. 1973 Academic Article GET IT
Times cited: 10
Effects of denervation on glycoproteins of rabbit gastrocnemius and soleus muscles. Experimental neurology. 1973 Academic Article GET IT
Times cited: 16
Erythrocyte protein phosphorylation. The Journal of biological chemistry. 1973 Academic Article GET IT
Times cited: 89
[Trophic influence of motor neurons on the glycoproteins of the phasic and tonic muscles. I. NANA and hexosamines]. Acta neurologica. 1973 Academic Article GET IT
The effects of electroshock seizures on potassium transport within synaptosomes from rat brain. Journal of neurochemistry. 1972 Academic Article GET IT
Times cited: 7
Brain synapses. An in vitro model for the study of seizures. Archives of internal medicine. 1972 Academic Article GET IT
Times cited: 9
The specificity and cross-reactivity of antisynaptosome antibodies as determined by sequential adsorption analysis. Journal of immunology (Baltimore, Md. : 1950). 1971 Academic Article GET IT
Times cited: 35
Incorporation of [14C]glucosamine into synaptosomes in vitro. Journal of neurochemistry. 1971 Academic Article GET IT
Times cited: 28
Diphenylhydantoin and potassium transport in isolated nerve terminals. The Journal of clinical investigation. 1971 Academic Article GET IT
Times cited: 8
Biochemical dysfunction and dementia. Contemporary neurology series. 1971 Academic Article GET IT
Times cited: 7
Zonal centrifuge profiles of rat brain homogenates: instability in sucrose, stability in iso-osmotic Ficoll-sucrose. Analytical biochemistry. 1971 Academic Article GET IT
Times cited: 26
Hexose monophosphate pathway in synapses. Journal of neurochemistry. 1970 Academic Article GET IT
Times cited: 52
Biochemical approaches to the study of synaptic function. Biological psychiatry. 1970 Academic Article GET IT
Times cited: 3
Carbohydrate metabolism of synapses. Neurology. 1970 Academic Article GET IT
The effects of electrically induced seizures on potassium transport within isolated nerve terminals. Neurology. 1970 Academic Article GET IT
Times cited: 3
The biologic half-life of brain-localized antisynapse radioantibodies. Journal of immunology (Baltimore, Md. : 1950). 1970 Academic Article GET IT
Times cited: 4
Synthesis de novo of purines in slices of rat brain and liver. Journal of neurochemistry. 1970 Academic Article GET IT
Times cited: 42
Biochemical studies of synapses in vitro. 3. Ionic activation of protein synthesis. The Journal of biological chemistry. 1969 Academic Article GET IT
Times cited: 68
Biochemical studies of synapses in vitro. II. Potassium transport. Biochemistry. 1969 Academic Article GET IT
Times cited: 52
Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase. The Journal of clinical investigation. 1968 Academic Article GET IT
Times cited: 84
Pyrimidine synthesis in tissue culture. Journal of neurochemistry. 1968 Academic Article GET IT
Times cited: 11
Kinetic studies on rat liver carbamyl phosphate synthetase. The Journal of biological chemistry. 1968 Academic Article GET IT
Times cited: 33
Purification and kinetic properties of brain orotidine 5'-phosphate decarboxylase. The Journal of biological chemistry. 1968 Academic Article GET IT
Times cited: 53
Biochemical studies of synapses in vitro. I. Protein synthesis. Biochemistry. 1968 Academic Article GET IT
Times cited: 164
Synapse function in vitro. Neurology. 1968 Academic Article GET IT
Times cited: 1
Brain polysomes: response to environmental stimulation. Science (New York, N.Y.). 1967 Academic Article GET IT
Times cited: 25
A generalized disorder of nervous system, skeletal muscle and heart resembling Refsum's disease and Hurler's syndrome. I. Clinical, pathologic and biochemical characteristics. The American journal of medicine. 1967 Academic Article GET IT
Times cited: 90
Inhibition of brain protein synthesis: an approach to the biochemical basis of neurological dysfunction in the amino-acidurias. Transactions of the New York Academy of Sciences. 1966 Academic Article GET IT
Times cited: 39
The chemical plasticity of the brain: the role of messenger RNA and polysomes in neural function. Recent advances in biological psychiatry. 1966 Review GET IT
Times cited: 1
Neurological Mutants of the Mouse. Science (New York, N.Y.). 1965 Academic Article GET IT
Times cited: 15
Effect of inhibition of RNA synthesis on neural information storage. Nature. 1965 Academic Article GET IT
Times cited: 16
TISSUE CULTURE STUDIES OF DEMYELINATION. Annals of the New York Academy of Sciences. 1965 Academic Article GET IT
Times cited: 93
A SPECTROPHOTOMETRIC ASSAY FOR THIOGALACTOSIDE TRANSACETYLASE. The Journal of biological chemistry. 1965 Academic Article GET IT
Times cited: 41
MULTIPLE MOLECULAR FORMS OF BETA-GALACTOSIDASE. Journal of molecular biology. 1965 Academic Article GET IT
Times cited: 27
MUTANT MICE (QUAKING AND JIMPY) WITH DEFICIENT MYELINATION IN THE CENTRAL NERVOUS SYSTEM. Science (New York, N.Y.). 1964 Academic Article GET IT
Times cited: 273
THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION. The Journal of experimental medicine. 1964 Academic Article GET IT
Times cited: 91
THYMOMA AND POLYMYOSITIS. ONSET OF MYASTHENIA GRAVIS AFTER THYMECTOMY: REPORT OF TWO CASES. Archives of internal medicine. 1964 Academic Article GET IT
Times cited: 31
Demyelination in cultures of rat cerebellum produced by experimental allergic encephalomyelitic serum. Transactions of the American Neurological Association. 1959 Academic Article GET IT
Times cited: 8

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 1960
A.B., Harvard College 1954

Contact

full name

Stanley Appel

VIVO Weill Cornell Medical College

Stanley Appel Professor of Neurology

Publications

selected publications

Background

education and training

Contact

full name